Weltrasemi Tablet

Adult dose

The initial recommended dose is 4 tablets, thereafter the interval should be at least 6 hours, not exceeding 16 tablets per day. Elderly patients usually receive the standard adult dose, but for those over 75 years old, a minimum interval of 6 hours should be maintained. Patients with moderate renal impairment should extend the administration interval to 12 hours. In patients with severe renal impairment and severe liver impairment, administration is either not recommended or not advised.

Child dose

Children over 12 years of age follow the same dosage and administration interval as adults.

This medication may cause liver damage, so individuals who regularly consume three or more alcoholic beverages daily should consult with a doctor or pharmacist before taking it. If skin rashes or hypersensitivity reactions occur while taking this medication, discontinue use immediately and inform medical personnel. Care should be taken with patients who have a history of seizures or factors that increase the risk of seizures. Rarely, serious allergic reactions may occur; if symptoms such as difficulty breathing or hives arise, immediate medical attention is necessary. Patients with severe asthma or respiratory issues should use this medication in a monitored environment due to the risk of respiratory depression. Caution is advised when used in combination with alcohol or central nervous system depressants, as severe drowsiness or respiratory depression may occur. Patients with head injuries or increased intracranial pressure should be careful when using this medication, as symptoms may worsen. This medication may cause psychological and physical dependence, so careful monitoring for dependence should be conducted with long-term use. Patients with impaired liver or kidney function, especially those with liver dysfunction, must consult with a specialist before taking this medication. This medication should not be used in children under 12 years old or in adolescents under 18 who have undergone tonsillectomy or adenoidectomy. This medication may cause obstructive sleep apnea or hypoxemia; periodic checks for these symptoms should be conducted. Due to the risk of hyponatremia, patients who are elderly or have risk factors for hyponatremia should be monitored through blood tests. Drowsiness or dizziness may occur during treatment, so caution should be exercised when driving or operating machinery. In case of overdose, severe respiratory depression, seizures, liver damage, etc., may occur; therefore, it is crucial to adhere to the prescribed dosage and contact a medical institution immediately in case of overdose. Pregnant or breastfeeding women should consult a doctor before taking this medication, and breastfeeding mothers should refrain from use for safety reasons. This medication may interact with other drugs, so if currently using other medications, it is essential to inform medical personnel and exercise caution.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by coughing and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, decreased urination

Mild side effects

• Decreased appetite
• insomnia
• depression
• dizziness
• headache
• drowsiness
• nausea
• vomiting
• constipation
• dry mouth

This medication should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it at a cool temperature below 25 degrees Celsius. Proper storage will maintain the effectiveness of the medication longer.

Appearance

Pale yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle